Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Mallardo D, Giannarelli D, Vitale MG, et al. Nivolumab serum concentration in metastatic melanoma patients could be related to outcome and enhanced immune activity: a gene profiling retrospective analysis. J Immunother Cancer 2022;10:e005132. doi: 10.1136/jitc-2022-005132
Figure 1 was incorrectly published in black and white. This has now been amended.